These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9710950)

  • 1. Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing.
    Purchase IF; Botham PA; Bruner LH; Flint OP; Frazier JM; Stokes WS
    Toxicol Sci; 1998 Jun; 43(2):86-101. PubMed ID: 9710950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement, reduction and refinement.
    Flecknell P
    ALTEX; 2002; 19(2):73-8. PubMed ID: 12098013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of animal procedures: alternatives in research, education and testing.
    Balls M
    Lab Anim; 1994 Jul; 28(3):193-211. PubMed ID: 7967458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century.
    Hartung T
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):277-90. PubMed ID: 20574902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Third FRAME Toxicity Committee: working toward greater implementation of alternatives in toxicity testing.
    Combes RD; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizou G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():635-42. PubMed ID: 23581152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why modification of the LD50 test will not be enough.
    Balls M
    Lab Anim; 1991 Jul; 25(3):198-206. PubMed ID: 1921314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in animal use and animal alternatives.
    De Greeve P; De Leeuw W; van Zutphen BF
    Altern Lab Anim; 2004 Jun; 32 Suppl 1A():13-9. PubMed ID: 23577430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
    Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
    Becker RA; Borgert CJ; Webb S; Ansell J; Amundson S; Portier CJ; Goldberg A; Bruner LH; Rowan A; Curren RD; Stott WT
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):18-22. PubMed ID: 16876299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and regulatory acceptance of new carcinogenicity tests.
    Spielmann H
    Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of eye irritancy testing: a regulatory perspective.
    Wilcox NL
    Lens Eye Toxic Res; 1992; 9(3-4):259-71. PubMed ID: 1301785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives to animal testing: research, trends, validation, regulatory acceptance.
    Huggins J
    ALTEX; 2003; 20(Suppl 1):3-61. PubMed ID: 14671702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A discussion of the impact of US chemical regulation legislation on the field of toxicity testing.
    Sullivan K; Beck N; Sandusky C; Willett C
    Toxicol In Vitro; 2011 Sep; 25(6):1231-6. PubMed ID: 21624455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in applying the three Rs of Russell & Burch to the testing of biological products.
    Balls M; Halder M
    Dev Biol (Basel); 2002; 111():3-13. PubMed ID: 12678219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chair on alternatives?
    Spielmann H
    ALTEX; 2002; 19(2):69-73. PubMed ID: 12098012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three Rs of Russell & Burch and the testing of biological products.
    Balls M; Straughan DW
    Dev Biol Stand; 1996; 86():11-8. PubMed ID: 8785939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.